[Hyperdynamic syndrome in myocardial infarct].
A total of 172 patients with myocardial infarction were investigated. The hyperdynamic syndrome was revealed in 72 patients within the first days of the disease, as manifested in increased cardiac performance, while 100 patients, whose hemodynamics were of normodynamic type, made up the control group. The hyperdynamic syndrome was shown to develop in the presence of elevated blood catecholamine and 11-OCS content and enhanced energy metabolism, reflecting a more pronounced response to stress. The development of the hyperdynamic syndrome increases the rates of complications associated with myocardial infarction, prolongs the duration of the disease and builds up the risk of fatal outcome due to cardiorrhexis.
D015062:11-Hydroxycorticosteroids / Q000097:blood; D002395:Catecholamines / Q000097:blood; D004562:Electrocardiography; D004734:Energy Metabolism; D005260:Female; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology; D009336:Necrosis; D013312:Stress, Physiological / Q000503:physiopathology; D013577:Syndrome; D013997:Time Factors
D015062:11-Hydroxycorticosteroids; D002395:Catecholamines
Giperdinamicheskiĭ sindrom pri infarkte miokarda.